Invest in

Biotech Breakthroughs

5.6%
4.4%
0.7%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See More
5.6%
4.4%
0.7%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Join over 100,000 Motif customers customizing, building, and sharing motifs.
Portfolio Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this thematic portfolio
Weight Segment & Stocks Symbol 1 YR Return
56.6% Research & Diagnostics 22.1%
15.2% Danaher Corporation DHR 30.4%
13.9% Thermo Fisher Scientific Inc. TMO 27.9%
5.1% 8xxxx 8xxxxxxx 8xxx 8xx 88.8%
4.5% 8xxxxxx 8xxxxxxxxxxx 8xx 8 88.8%
4.3% 8xxxx 8xxxxxxxxxx 8xxxxxxxxxxx 8xx 88.8%
3.5% 8xxxxxx 8xxxxxxxxxxx 8xxx 8xx 8xx 88.8%
3.3% 8xxxxx 8xxxxxxxxxx 8xx 88.8%
3.3% 8xxxxx 8xxx 8xxx 88.8%
2.7% 8xxxxxxxxxxxxx 8xxxxxxxxxxxx 8xxx 8xx 88.8%
1.0% 8xxxxxxxxxx 8xxx 8xx 88.8%
19.5% Other Biotech 2.7%
13.8% Amgen Inc. AMGN 2.6%
3.7% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.0% 8xxxxx 8xxxxxxxxxxx 8x 8xxx 88.8%
0.9% 8xx 8xxxxxxxx 8xxx 8xxx 88.8%
15.5% Mature Biotechnology 7.5%
10.5% 8xxxxx 8xxxxxxx 8xxx 8xxx 88.8%
5.1% 8xxxxx 8xxx 8xxx 88.8%
3.8% Commercial Growth Biotech 5.3%
3.8% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
2.4% Early Commercial Biotech 8.6%
2.4% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
2.1% Development Stage Biotech 5.1%
1.2% 8xxxxxxxx 8x 8xxxx 8xx 8xxx 88.8%
0.9% 8xxxxxxxxx 8xxxxxxxx 8xxx 8xxx 88.8%
Quotes delayed 15 mins. Currently May 19, 2019 11:30:34 PM. Fields are marked with -- when data is unavailable.